In This Article Introduction

Antidepressants Antihistamines Growth Hormones Opioid Analgesics Antihistamines Clarinex (desloratadine) Syrup
Business: Schering
Drug Favourable reception Compartmentalization: Master copy New Drug Use (Approval Date: 9/3/04)
Reason: This new drug use for Clarinex (desloratadine) Syrup provides for the break of the consonant and non-nasal symptoms of perennial allergic rhinitis, and the symptomatic assuagement of pruritus, simplification in the telephone number of hives, and size of hives, in patients with chronic idiopathic urticaria in children 6 months to 2 long time of age.
Dosing: Dosing is based on age:

Children 6 to 11 time period of age: The recommended dose of desloratadine syrup is 1 teaspoonful (2.5 mg in 5 mL) once daily.
Children 12 months to 5 time period of age: The recommended dose of desloratadine syrup is 1/2 teaspoonful (1.25 mg in 2.5 mL) once daily.
Children 6 to 11 months of age: The recommended dose of desloratadine syrup is 2 mL (1.0 mg) once daily.
Clinical Summary: Figure pediatric clinical studies were conducted to assess the efficacy of desloratadine in allergic rhinitis, chronic idiopathic urticaria, and in subjects who were candidates for antihistamine therapy.
The clinical studies were 15-day, double-blind, placebo-controlled prophylactic studies that enrolled 246 pediatric subjects 6 months to 11 class of age.
This is a part of article In This Article Introduction Taken from "Generic Clarinex (Desloratadine) Page" Information Blog